![Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release | ACS Nano Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.2c05195/asset/images/medium/nn2c05195_0005.gif)
Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release | ACS Nano
Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release | ACS Nano
![Cancers | Free Full-Text | Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases Cancers | Free Full-Text | Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases](https://pub.mdpi-res.com/cancers/cancers-14-00047/article_deploy/html/images/cancers-14-00047-g002.png?1640252016)
Cancers | Free Full-Text | Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases
![Progress and application of circulating tumor cells in non-small cell lung cancer: Molecular Therapy - Oncolytics Progress and application of circulating tumor cells in non-small cell lung cancer: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/2377921c-98be-475a-a85c-63997437472a/fx1.jpg)
Progress and application of circulating tumor cells in non-small cell lung cancer: Molecular Therapy - Oncolytics
![JCM | Free Full-Text | A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer JCM | Free Full-Text | A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer](https://pub.mdpi-res.com/jcm/jcm-08-01772/article_deploy/html/images/jcm-08-01772-g001.png?1575024877)